Geometric mean titer (GMT) of anti-Vi-IgG antibodies following immunization.

Figshare2019-02-13 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Geometric_mean_titer_GMT_of_anti-Vi-IgG_antibodies_following_immunization_/7714796 数据链接链接失效反馈

官方服务：

资源简介：

Geometric mean titer (GMT) of anti-Vi-IgG antibodies following immunization.

创建时间：

2019-02-13

Dynamic trend of neutralizing antibody GMTs (95%CI) for EV71 FCP-As.

疫苗免疫原性

中和抗体动态监测

Female BALB/c mice (4–6 weeks old) were i.p. inoculated with three EV71 FCP-As (V1, V2, and V3) containing 200 U antigen. The sera were isolated and tested at 7, 14, 21, 28, 56 and 84 d post-inoculati

NIAID Data Ecosystem100

Dataset from Phase IV Open Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Measles-Mumps-Rubella (MMR) Vaccine When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.

疫苗免疫原性

疫苗安全性监测

To evaluate the safety and immunogenicity of GSK Biologicals' live attenuated MMR vaccine (Priorix) in a local population in Singapore. The vaccine was administered as a single dose to healthy childre

NIAID Data Ecosystem10

Dataset from A Phase 3b, Controlled, Open-Label, Multi-Center Study to Evaluate Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's Meningococcal ACWY Conjugate Vaccine (Menveo), Administered to Healthy Individuals 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination

疫苗免疫原性

加强免疫

The purpose/aim of this study is to assess the safety and antibody response to vaccination with a booster dose of Menveo given 4-6 years after primary MenACWY vaccination and to assess the safety and

NIAID Data Ecosystem10

疫苗免疫原性

免疫应答

aGroups of 5 WT or IL-23 KO mice (p19M KO and p19G KO) were infected with 105 LVS ID and sera collected at Day 42, or were anesthetized and infected with 2×103 LVS IN and sera collected at day 35. Ser

Figshare2015-12-02 更新40

MOESM1 of Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A

疫苗免疫原性

抗体滴度分析

Additional file 1. AMA1 IgG subclass titers, total IgG titers, and cytophilic ratios for AMA1 vaccine and control groups.

Figshare2019-01-19 更新10